A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Clinical trial NCT02715804 · TERMINATED

Trial details

NCT number: NCT02715804
Sponsor: Halozyme Therapeutics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Ductal Carcinoma

Start date: 2016-03-14
Primary completion: 2019-11-04
Enrollment: 492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.